$313.20
1.26% yesterday
NYSE, Nov 03, 10:00 pm CET
ISIN
US0367521038
Symbol
ELV

Elevance Health Stock price

$313.19
-37.31 10.64% 1M
-103.11 24.77% 6M
-55.71 15.10% YTD
-104.67 25.05% 1Y
-220.67 41.33% 3Y
+19.73 6.72% 5Y
+176.14 128.52% 10Y
+239.29 323.80% 20Y
NYSE, Closing price Mon, Nov 03 2025
-4.01 1.26%

Key metrics

Basic
Market capitalization
$69.6b
Enterprise Value
$93.0b
Net debt
$23.4b
Cash
$8.7b
Shares outstanding
225.2m
Valuation (TTM | estimate)
P/E
12.7 | 10.4
P/S
0.4 | 0.4
EV/Sales
0.5 | 0.5
EV/FCF
25.0
P/B
1.6
Dividends
DPS
$6.84
Yield 1Y | 5Y
2.2% | 1.3%
Growth 1Y | 5Y
4.9% | 12.5%
Payout 1Y | 3Y
25.4% | 23.4%
Increased
15 Years
Financials (TTM | estimate)
Revenue
$194.8b | $198.9b
EBITDA
$9.1b | $10.6b
EBIT
$8.5b | $9.8b
Net Income
$5.5b | $6.8b
Free Cash Flow
$3.7b
Growth (TTM | estimate)
Revenue
12.0% | 12.5%
EBITDA
-9.8% | 9.1%
EBIT
-10.7% | 6.7%
Net Income
-13.8% | 13.7%
Free Cash Flow
337.3%
Margin (TTM | estimate)
Gross
-
EBITDA
4.7% | 5.3%
EBIT
4.4%
Net
2.8% | 3.4%
Free Cash Flow
1.9%
Financial Health
Equity Ratio
35.4%
Return on Equity
14.5%
ROCE
7.0%
ROIC
-
Debt/Equity
0.7
More
EPS
$24.7
FCF per Share
$16.5
Short interest
1.2%
Employees
104k
Rev per Employee
$1.7m
Show more

Is Elevance Health a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,030 stocks worldwide.

Elevance Health Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a Elevance Health forecast:

17x Buy
59%
12x Hold
41%

Analyst Opinions

29 Analysts have issued a Elevance Health forecast:

Buy
59%
Hold
41%

Financial data from Elevance Health

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
194,820 194,820
12% 12%
100%
- Policy Benefits 143,658 143,658
15% 15%
74%
51,162 51,162
5% 5%
26%
- SG&A - -
-
-
- Other operating expenses 42,041 42,041
9% 9%
22%
9,121 9,121
10% 10%
5%
- Depreciation and Amortization 644 644
4% 4%
0%
8,477 8,477
11% 11%
4%
- Interest Expense 1,376 1,376
25% 25%
1%
- Tax Expense 1,573 1,573
18% 18%
1%
Net Profit 5,533 5,533
14% 14%
3%

In millions USD.

Don't miss a Thing! We will send you all news about Elevance Health directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Elevance Health Stock News

Positive
Seeking Alpha
about 2 hours ago
Electronic Arts' shares outperformed the broader market during the period, driven by renewed investor confidence and momentum surrounding several high-profile product announcements. eBay's shares surged after reporting a strong second-quarter earnings report, bolstering confidence in the company's position in the marketplace. Elevance Health was the top underperformer over the period. Much of t...
Positive
Seeking Alpha
5 days ago
Alphabet shares rose 38% during the quarter, which represents a striking $810 billion increase in market value. Samsung shares rose 36% in the quarter, adding over $100 billion of market value. Elevance's share price declined by 16%, making it our largest negative contributor.
Positive
Seeking Alpha
11 days ago
Elevance Health reaffirmed its long-term goal of targeting at least 12% average annual growth in adjusted diluted EPS. ELV trades at a forward P/E of 11.5, below UNH's at 22, suggesting undervaluation if growth continues from 2026. The key risk remains a health benefit ratio above 90%, which will be closely monitored in upcoming quarters.
More Elevance Health News

Company Profile

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Head office United States
CEO Gail Boudreaux
Employees 104,200
Founded 1944
Website www.elevancehealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today